Physician
Progressive Mri, LLC
Progressive Mri, LLC was paid $916K by Medicaid between Jan 2018 and Mar 2024, across 29 billing codes. Its largest line is 73721, Magnetic resonance imaging, any joint of lower extremity; without contrast material — 61% of everything it billed.
33Billing provider infoPROGRESSIVE MRI, LLC
HAGERSTOWN, MD 21740
HAGERSTOWN, MD 21740
33aNPI1689783185assigned 08/29/2006
33bProvider typeDiagnostic Radiology Physician
28Total paid$916K
24GClaims16,423
24DCodes billed29
24AFirst – last monthJan 2018 – Mar 2024
Compared with peers
Next to other Diagnostic Radiology Physician providers in Maryland
Rank by total paid#10 of 70
Median peer was paid$6K
This provider vs. median154×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 530 | $37K | |
| 2019 | 414 | $21K | |
| 2020 | 4,859 | $265K | |
| 2021 | 6,899 | $264K | |
| 2022 | 2,442 | $192K | |
| 2023 | 1,111 | $122K | |
| 2024incomplete | 168 | $14K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 61% | 3,702 | 2,784 | $559K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 17% | 2,317 | 1,313 | $153K |
| 73221 | 5.9% | 439 | 270 | $54K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 4.1% | 439 | 366 | $37K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 2.7% | 95 | 64 | $25K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 2.3% | 149 | 117 | $21K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 1.6% | 436 | 363 | $14K |
| 72141 | 1.3% | 207 | 129 | $11K | |
| 72110 | 1.2% | 365 | 289 | $11K | |
| 71046 | Radiologic examination, chest; 2 views | 1.0% | 451 | 388 | $9K |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 400 | 271 | $7K |
| 93976 | <1% | 45 | 37 | $5K |
17 more codes
| 76830 | Ultrasound, transvaginal | <1% | 29 | $2K |
| G9637 | Final reports with documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique) | <1% | 441 | $1K |
| 76536 | <1% | 18 | $1K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 12 | $972.18 |
| 72082 | <1% | 14 | $595.10 | |
| G1011 | Clinical decision support mechanism, qualified tool not otherwise specified, as defined by the medicare appropriate use criteria program | <1% | 5,340 | $519.05 |
| 72050 | <1% | 20 | $483.44 | |
| 73562 | <1% | 20 | $445.92 | |
| G9557 | Final reports for ct, cta, mri or mra studies of the chest or neck without an incidentally found thyroid nodule < 1.0 cm noted or no nodule found | <1% | 151 | $355.46 |
| 74018 | <1% | 22 | $329.41 | |
| 73030 | <1% | 36 | $307.73 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 14 | $161.22 |
| 99072 | <1% | 726 | $101.40 | |
| G9551 | Final reports for imaging studies without an incidentally found lesion noted | <1% | 213 | $33.21 |
| G9327 | Ct studies performed reported to a radiation dose index registry that is capable of collecting at a minimum all necessary data elements | <1% | 44 | $13.46 |
| 7025F | 0% | 243 | $0.00 | |
| 3341F | 0% | 35 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSTARR, ADAM (CEO)